Ketorolac Dose Ceiling Effect for Pediatric Headache in the Emergency Department
Truncating the maximum intravenous ketorolac dose in pediatric patients at least 60 kg in weight to 15 mg compared with 30 mg results in effective analgesia in pediatric patients with headache. Future research could explore differences in admission rates, treatment of other indications, or treatment with multiple-dose regimens.
Authors
- Manu Madhok (ORCID: https://orcid.org/0000-0003-2461-1976)
- Mike Finch
- Mike Raschka
- Brian Lefchak (ORCID: https://orcid.org/0000-0002-6897-6945)
- Danielle Fuentes Morgan (ORCID: https://orcid.org/0000-0002-0459-6580)
Institutions
- Children's Minnesota (US)
Publication Details
- Journal
- The Journal of Pediatric Pharmacology and Therapeutics
- Published
- 2024-10-01
- DOI
- https://doi.org/10.5863/1551-6776-29.5.494
- Citations
- 1
- Primary Topic
- Anesthesia and Pain Management
- Type
- article
- Field-Weighted Citation Impact
- 0.57